| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.019 | 0.7 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.0074 | 0.9 |